[Future trends in anticancer chemotherapy]

Nihon Rinsho. 2002 May:60 Suppl 5:726-32.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials as Topic
  • Drug Design
  • Drug Therapy / trends*
  • Drugs, Investigational
  • Endothelial Growth Factors / immunology
  • Forecasting
  • Gefitinib
  • Humans
  • Intercellular Signaling Peptides and Proteins / immunology
  • Lung Neoplasms / drug therapy*
  • Lymphokines / immunology
  • Quinazolines
  • Recombinant Proteins
  • Trastuzumab
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Drugs, Investigational
  • Endothelial Growth Factors
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Quinazolines
  • Recombinant Proteins
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Trastuzumab
  • Gefitinib